Oligonucleotide derivatives directed against human bcl-xl and human bcl-2 mrna
A Standard patent application filed on 26 April 2000 credited to Zangemeister-Wittke, Uwe
;
Huesken, Dieter
;
Ludke, Gerd
Details
Application number :
44025
Application type :
Standard
Application status :
LAPSED
Under opposition :
No
Proceeding type :
Invention title :
Oligonucleotide derivatives directed against human bcl-xl and human bcl-2 mrna